Comparison of FDG PET/CT and Bone Marrow Biopsy Results in Patients with Diffuse Large B Cell Lymphoma with Subgroup Analysis of PET Radiomics

Whether FDG PET/CT can replace bone marrow biopsy (BMBx) is undecided in patients with diffuse large B cell lymphoma (DLBCL). We compared the visual PET findings and PET radiomic features, with BMBx results. A total of 328 patients were included; 269 (82%) were PET-negative and 59 (18%) were PET-pos...

Whakaahuatanga katoa

Ngā taipitopito rārangi puna kōrero

Ngā kaituhi matua:	Eun Ji Han, Joo Hyun O, Hyukjin Yoon, Seunggyun Ha, Ie Ryung Yoo, Jae Won Min, Joon-Il Choi, Byung-Ock Choi, Gyeongsin Park, Han Hee Lee, Young-Woo Jeon, Gi-June Min, Seok-Goo Cho
Hōputu:	Artigo
Reo:	Inglês
I whakaputaina:	MDPI AG 2022-01-01
Rangatū:	Diagnostics
Ngā marau:	diffuse large B cell lymphoma FDG PET/CT radiomics
Urunga tuihono:	https://www.mdpi.com/2075-4418/12/1/222
Ngā Tūtohu:	Tāpirihia he Tūtohu Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!